Found: 21
Select item for more details and to access through your institution.
Relationship of the urine cortisol level with the performance status of patients with lung cancer: a retrospective study.
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 7, p. 2129, doi. 10.1007/s00520-014-2585-5
- By:
- Publication type:
- Article
Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient With Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case Report.
- Published in:
- In Vivo, 2024, v. 38, n. 3, p. 1509, doi. 10.21873/invivo.13599
- By:
- Publication type:
- Article
Case Series of Pleomorphic Carcinoma of the Lung Treated With Immune Checkpoint Inhibitors.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Systemic dissemination of chronic necrotizing pulmonary aspergillosis in an elderly woman without comorbidity: a case report.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Miliary brain metastasis presenting with calcification in a patient with lung cancer: a case report.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Lung Cancer Wherein Durvalumab Induced Both Anti-CRMP-5 Antibody-related Paraneoplastic Neurological Syndromes and Neurological Adverse Events.
- Published in:
- Internal Medicine, 2024, v. 54, n. 7, p. 1009, doi. 10.2169/internalmedicine.1771-23
- By:
- Publication type:
- Article
Relationship between Carnitine Pharmacokinetics and Fatigue in Patients Treated with Cisplatin-Containing Chemotherapy.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 1/2, p. 42, doi. 10.1159/000455255
- By:
- Publication type:
- Article
Utility of creatinine/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: A retrospective study.
- Published in:
- Journal of International Medical Research, 2015, v. 43, n. 4, p. 573, doi. 10.1177/0300060515579116
- By:
- Publication type:
- Article
An observational study on the efficacy of targeted therapy for pulmonary sarcomatoid carcinoma.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01046-5
- By:
- Publication type:
- Article
Clinical Parameters for Predicting the Survival in Patients with Squamous and Non-squamous-cell NSCLC Receiving PD-1 Inhibitor Therapy.
- Published in:
- Pathology & Oncology Research, 2020, v. 26, n. 1, p. 327, doi. 10.1007/s12253-018-0473-x
- By:
- Publication type:
- Article
Elevated levels of plasma lactate dehydrogenase is an unfavorable prognostic factor in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer, receiving treatment with gefitinib or erlotinib.
- Published in:
- Molecular & Clinical Oncology, 2016, v. 4, n. 5, p. 774, doi. 10.3892/mco.2016.779
- By:
- Publication type:
- Article
Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib.
- Published in:
- Molecular & Clinical Oncology, 2015, v. 3, n. 4, p. 62, doi. 10.3892/mco.2015.568
- By:
- Publication type:
- Article
Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1618, doi. 10.1111/1759-7714.14907
- By:
- Publication type:
- Article
Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin-induced mouse model of asthma.
- Published in:
- Respirology, 2013, v. 18, n. 2, p. 332, doi. 10.1111/j.1440-1843.2012.02284.x
- By:
- Publication type:
- Article
Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 12, p. 1006, doi. 10.3390/diagnostics10121006
- By:
- Publication type:
- Article
Comparison of the efficacy of first‑/second‑generation EGFR‑tyrosine kinase inhibitors and osimertinib for EGFR‑mutant lung cancer with negative or low PD‑L1 expression.
- Published in:
- Molecular & Clinical Oncology, 2024, v. 20, n. 6, p. N.PAG, doi. 10.3892/mco.2024.2741
- By:
- Publication type:
- Article
Associations of immune checkpoint inhibitor therapy efficacy with clinical parameters and tumor‑infiltrating CD68‑positive cell counts in patients with EGFR‑mutant non‑small cell lung cancer.
- Published in:
- Molecular & Clinical Oncology, 2023, v. 18, n. 5, p. N.PAG, doi. 10.3892/mco.2023.2634
- By:
- Publication type:
- Article
Ionizing radiation suppresses FAP-1 mRNA level in A549 cells via p53 activation
- Published in:
- FEBS Letters, 2006, v. 580, n. 18, p. 4387, doi. 10.1016/j.febslet.2006.07.003
- By:
- Publication type:
- Article
Clinical Course After Initiation of Nivolumab Therapy in Patients with EGFR-Mutated Non-Small Cell Lung Cancer With or Without Pd-L1 Expression.
- Published in:
- Oncology & Therapy, 2017, v. 5, n. 2, p. 181, doi. 10.1007/s40487-017-0053-3
- By:
- Publication type:
- Article
Peripheral CD4 memory T cells predict the efficacy of immune checkpoint inhibitor therapy in patients with non-small cell lung cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-37736-3
- By:
- Publication type:
- Article
Usefulness of the Palliative Prognostic Index in patients with lung cancer.
- Published in:
- Medical Oncology, 2014, v. 31, n. 9, p. 1, doi. 10.1007/s12032-014-0154-x
- By:
- Publication type:
- Article